Intra-Cellular Therapies Inc
Intra-Cellular Therapies's GHG Emissions Data Preview
In 2023, Intra-Cellular Therapies completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources).
However, Intra-Cellular Therapies has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Location-Based | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Verified Sources Behind Intra-Cellular Therapies’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Intra-Cellular Therapies’s data sources below and access millions more through our Disclosure Search.
Insights into Intra-Cellular Therapies's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Intra-Cellular Therapies amounted to 3,907 metric tons of CO2 equivalent. This figure reflects direct emissions from owned or controlled sources (Scope 1).a
Intra-Cellular Therapies's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Intra-Cellular Therapies's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Intra-Cellular Therapies were 3,907 metric tons of CO₂ equivalent (tCO₂e).a